EMED Share Price Performance
US$0.0001
-0.00 (-66.67%)
Price US$0.0001
Share PriceUS$0.0001
Electromedical Technologies, Inc. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
EMED Community Narratives
There are no narratives available yet.
Recent EMED News & Updates
Electromedical Technologies, Inc. Key Details
Last Reported Earnings
Sep 30, 2024
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -0.00047
- Gross Margin
- 75.08%
- Net Profit Margin
- -182.41%
- Debt/Equity Ratio
- -38.5%
Electromedical Technologies, Inc. Competitors
Snowflake Analysis
About EMED
- Founded
- 2002
- Employees
- 6
- CEO
- WebsiteView website
Electromedical Technologies, Inc., a bioelectronics manufacturing and marketing company, provides medical devices for pain management in the United States. The company offers WellnessPro Plus, a bioelectronics therapy prescription device that is used by consumers and health care professionals to relieve chronic and acute pain. It also develops WellnessPro POD, a compact clinical-grade wearable device for pain management; and Wellness ION Pen, an interferential cold laser used to deliver targeted frequency stimulation to improve circulation and tissue healing, and reduce inflammation and pain. The company serves chiropractors, physiotherapists, pain management doctors and clinicians, natural medicine doctors, sports medicine doctors, and athletic trainers. Electromedical Technologies, Inc. was founded in 2002 and is headquartered in Scottsdale, Arizona.
Market Insight
Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading
U.S. Market Performance
- 7 Days: 0.9%
- 3 Months: 8.7%
- 1 Year: 18.4%
- Year to Date: 14.8%
Over the last 7 days, the market has remained flat, although notably the Healthcare sector gained 6.4% in that time. As for the longer term, the market has risen 18% in the past 12 months. As for the next few years, earnings are expected to grow by 15% per annum. Market details ›